Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 10, 2010 - Issue 5
Submit an article Journal homepage
1,498
Views
40
CrossRef citations to date
0
Altmetric
Editorial

Should olfactory dysfunction be used as a biomarker of Alzheimer’s disease?

Daniel W Wesson Emotional Brain Institute, Nathan S Kline Institute for Psychiatric Research, New York University School of Medicine, Orangeburg, NY 10962, USA. [email protected]
,
Donald A Wilson Emotional Brain Institute, Nathan S Kline Institute for Psychiatric Research, New York University School of Medicine, NY, USA
&
Ralph A Nixon Center for Dementia Research, Nathan S Kline Institute for Psychiatric Research, New York University School of Medicine, NY, USA
Pages 633-635 | Published online: 09 Jan 2014

References

  • Craig-Schapiro R, Fagan AM, Holtzman DM. Biomarkers of Alzheimer’s disease. Neurobiol. Dis.35(2), 128–140 (2009).
  • Jack CRJ, Knopman DS, Jagust WJ et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol.9(1), 119–128 (2010).
  • Doty RL. Olfactory capacities in aging and Alzheimer’s disease. Psychophysical and anatomic considerations. Ann. NY Acad. Sci.640, 20–27 (1981).
  • Murphy C. Loss of olfactory function in dementing disease. Physiol. Behav.66(2), 177–182 (1999).
  • Cronin-Golomb A, Rizzo J, Corkin S, Growdon J. Visual function in Alzheimer’s disease and normal aging. Ann. NY Acad. Sci.640, 28–35 (1991).
  • Cacace AT. Aging, Alzheimer’s disease, and hearing impairment: highlighting relevant issues and calling for additional research. Am. J. Audiol.16(1), 2–3 (2007).
  • Eichenbaum HB, Otto TA, Wible CG, Piper JM. Building a model of the hippocampus in olfaction and memory. In: Olfaction: a Model System for Computational Neuroscience. Davis JL, Eichenbaum HB (Eds). The MIT Press, MA, USA 167–210 (1991).
  • Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases. Arch. Neurol.55(1), 84–90 (1998).
  • Gilbert PE, Murphy C. The effect of the ApoE ε4 allele on recognition memory for olfactory and visual stimuli in patients with pathologically confirmed Alzheimer’s disease, probable Alzheimer’s disease, and healthy elderly controls. J. Clin. Exp. Neuropsychol.26(6), 779–794 (2004).
  • Devanand DP, Liu X, Tabert MH et al. Combining early markers strongly predicts conversion from mild cognitive impairment to Alzheimer‘s disease. Biol. Psychiatry64(10), 871–879 (2008).
  • Kovacs T. Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders. Ageing Res. Rev.3, 215–232 (2004).
  • Price J, Davis P, Morris J, White D. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer’s disease. Neurobiol. Aging12(4), 295–312 (1991).
  • Wilson RS, Arnold SE, Schneider JA, Tang Y, Bennett DA. The relationship between cerebral Alzheimer’s disease pathology and odour identification in old age. J. Neurol. Neurosurg. Psychiatry78(1), 30–35 (2007).
  • Attems J, Jellinger KA. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Clin. Neuropathol.25(6), 265–271 (2006).
  • Macknin JB, Higuchi M, Lee VM, Trojanowski JQ, Doty RL. Olfactory dysfunction occurs in transgenic mice overexpressing human tau protein. Brain Res.1000(1–2), 174–178 (2004).
  • Wesson DW, Levy E, Nixon RA, Wilson DA. Olfactory dysfunction correlates with b-amyloid plaque burden in an Alzheimer’s disease mouse model. J. Neurosci.30(2), 505–514 (2010).
  • Westervelt HJ, Carvalho J, Duff K. Presentation of Alzheimer’s disease in patients with and without olfactory deficits. Arch. Clin. Neuropsychol.22(1), 117–122 (2007).
  • Doty RL, Kobal G. Current trends in the measurement of olfactory function. In: Handbook of Olfaction and Gustation. Doty RL (Ed.). Marcel Dekker, NY, USA (1995).
  • Alzheimers Association. Alzheimer’s Disease Facts and Figures. Alzheimer’s Association, DC, USA (2009).
  • Hawkes C. Olfaction in neurodegenerative disorder. Mov. Disord.18(4), 364–372 (2003).
  • Williams SS, Williams J, Combrinck M, Christie S, Smith AD, McShane R. Olfactory impairment is more marked in patients with mild dementia with Lewy bodies than those with mild Alzheimer disease. J. Neurol. Neurosurg. Psychiatry80(6), 667–670 (2009).
  • McLaughlin NCR, Westervelt HJ. Odor identification deficits in frontotemporal dementia: a preliminary study. Arch. Clin. Neuropsychol.23(1), 119–123 (2008).
  • Kobal G, Hummel T, Sekinger T, Barz S, Roscher S, Wolf S. “Sniffin’ sticks”: screening of olfactory performance. Rhinology34(4), 222–226 (1996).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.